Study guide
15.2 Thyroid & Parathyroid Disease
NBME Comprehensive Basic Science Examination CBSE
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Navigation
1.1 Current Exam Facts & Administration 1.2 Content Blueprint & Physician Tasks 1.3 Scoring, Score Reports & Step 1 Readiness
2 Human Development
2.1 Embryology & Congenital Development Patterns 2.2 Normal Age-Related Findings & Well-Patient Care
3 Blood & Hematologic Disease
3.1 Hematopoiesis, RBC Disorders & Anemias 3.2 Hemostasis, Thrombosis & Coagulopathies 3.3 WBC Disorders, Leukemia & Lymphoma Mechanisms
4 Immune System
4.1 Innate & Adaptive Immunity Mechanisms 4.2 Hypersensitivity, Autoimmunity & Immunodeficiency 4.3 Transplant Immunology & Immune Pharmacology
5 Nervous System Anatomy & Disease
5.1 Neuroanatomy Localization & Pathways 5.2 Stroke, Infection, Demyelination & Trauma 5.3 Seizures, Movement Disorders & Neurodegeneration 5.4 Special Senses: Eye & Ear Mechanisms
6 Behavioral Health
6.1 Psychiatric Disorders & Diagnostic Patterns 6.2 Psychopharmacology Mechanisms 6.3 Neurotransmitters, Learning & Behavioral Science
7 Musculoskeletal System
7.1 Bone Physiology, Fracture Healing & Bone Pathology 7.2 Joint Disease, Rheumatology & Connective Tissue 7.3 Muscle, NMJ & Peripheral Nerve Disorders
8 Skin & Soft Tissue
8.1 Dermatopathology High-Yield Lesions 8.2 Inflammation, Wound Healing & Soft-Tissue Infection
9 Cardiovascular Pathophysiology
9.1 Cardiac Cycle, Hemodynamics & Murmurs 9.2 Ischemic Heart Disease & Cardiomyopathy 9.3 Congenital & Valvular Heart Disease 9.4 Vascular Pathology & Hypertension
10 Cardiovascular Pharmacology
10.1 Antihypertensives, Heart Failure & Antiarrhythmics 10.2 Antiplatelets, Anticoagulants & Lipid Drugs
11 Respiratory System
11.1 Pulmonary Mechanics & Gas Exchange 11.2 Obstructive, Restrictive & Vascular Lung Disease 11.3 Pulmonary Infections, Neoplasms & Respiratory Pharmacology
12 Renal Physiology & Electrolytes
12.1 Nephron Transport & Renal Physiology 12.2 Electrolyte Disorders 12.3 Acid-Base Physiology & Compensation
13 Renal Pathology
13.1 Glomerular Disease Mechanisms 13.2 Tubulointerstitial, Vascular & Stone Disease
14 Gastrointestinal System
14.1 GI Physiology, Motility & Digestion 14.2 Esophagus, Stomach & Intestinal Pathology 14.3 Liver, Biliary Tree & Pancreas 14.4 GI Microbiology, Nutrition & Malabsorption
15 Endocrine System
15.1 Hormone Signaling & Hypothalamic-Pituitary Axes 15.2 Thyroid & Parathyroid Disease 15.3 Adrenal Disorders & Steroid Pharmacology 15.4 Diabetes, Glucose Homeostasis & Metabolic Syndrome
16 Reproductive System
16.1 Male & Female Reproductive Physiology 16.2 Pregnancy, Placenta & Developmental Toxicology 16.3 Reproductive Pathology & Hormone-Related Neoplasia
17 Multisystem Processes & Disorders
17.1 Cell Injury, Inflammation & Repair 17.2 Neoplasia Principles & Tumor Biology 17.3 Infection, Sepsis & Multisystem Microbial Disease 17.4 Genetics, Inborn Errors & Environmental Toxicology
18 Biostatistics & Epidemiology
18.1 Study Design, Bias & Causation 18.2 Diagnostic Test Metrics & Screening 18.3 Epidemiology Measures & Population Health
19 Social Sciences & Communication
19.1 Ethics Principles & Decision-Making Capacity 19.2 Communication Skills & Difficult Conversations 19.3 Professionalism, Systems & Practice-Based Learning
20 Integrated Disciplines Capstone
20.1 High-Yield Microbiology Anchors Across Systems 20.2 High-Yield Biochemistry & Molecular Mechanisms 20.3 Integrated Pharmacology Strategy & Exam-Day Execution
15.2 Thyroid & Parathyroid Disease
Key Takeaways Explain This Topic AI
Thyroid hormone synthesis requires iodide trapping (NIS), organification and coupling by TPO on thyroglobulin, and peripheral T4→T3 conversion by deiodinases; TSH (cAMP) drives the follicular cell.
Graves disease is TSIs (stimulating TSH-receptor antibodies); Hashimoto thyroiditis is autoimmune destruction often with anti-TPO/anti-thyroglobulin antibodies and risk of initial hyperthyroid phase then hypothyroidism.
Papillary thyroid cancer (most common, Orphan Annie nuclei, psammoma bodies, RET/PTC or BRAF) has excellent prognosis; follicular invades hematogenously; medullary arises from C cells (calcitonin, MEN2, RET); anaplastic is aggressive in elderly.
PTH raises serum Ca2+ (bone resorption, renal Ca reabsorption, 1,25-(OH)2D activation) and lowers phosphate (phosphaturia); PTHrP mimics PTH receptor activation in humoral hypercalcemia of malignancy; calcitonin lowers Ca2+ modestly.
Primary hyperparathyroidism: high/inappropriately normal PTH + high Ca2+; secondary: high PTH driven by low Ca2+/high PO4/low vitamin D (CKD classic); MEN1 (3 Ps), MEN2A (MTC, pheo, hyperparathyroidism), MEN2B (MTC, pheo, mucosal neuromas, marfanoid).
Last updated: August 2026
15.2 Thyroid & Parathyroid Disease
Quick Answer: Iodide trap → TPO organification/coupling → T4/T3; T4 converts to active T3 peripherally. Graves = stimulating TSH-receptor Ab; Hashimoto = destructive autoimmunity. PTH ↑Ca2+/↓PO4 via bone, kidney, and 1,25-D; PTHrP drives many malignant hypercalcemias. Know thyroid cancer associations and MEN1/2 patterns.
Thyroid and parathyroid content on the CBSE rewards stepwise physiology: where iodine is handled, which antibody stimulates versus destroys, how calcium is defended minute-to-minute, and which neoplasm or MEN syndrome matches the vignette’s "extra" findings.
Thyroid Hormone Synthesis and Activation
Follicular cells synthesize thyroid hormone on thyroglobulin in the colloid.
Iodide trapping: Basolateral Na+/I− symporter (NIS) concentrates iodide (stimulated by TSH). Competitive anions (perchlorate historically) can block uptake.
Oxidation and organification: Thyroid peroxidase (TPO) oxidizes iodide and iodinates tyrosyl residues on thyroglobulin → MIT and DIT.
Coupling: TPO couples MIT+DIT → T3 and DIT+DIT → T4 (thyroxine is the major secreted product).
Endocytosis and proteolysis: Stimulated follicular cells take up colloid, free T4/T3, and release them into blood bound mainly to TBG (also transthyretin and albumin).
Peripheral activation: Type 1 and type 2 deiodinases convert T4 → active T3 ; type 3 deiodinase produces inactive reverse T3 (rT3). Illness can raise rT3 (euthyroid sick patterns).
TSH from the anterior pituitary acts via Gs-cAMP on follicular cells to promote every step of synthesis and growth. TRH from the hypothalamus stimulates TSH. Free T3/T4 provide negative feedback on TRH and TSH.
T3 binds nuclear thyroid hormone receptors and regulates basal metabolic rate, cardiac β-receptor expression, bone turnover, and CNS development (congenital hypothyroidism → cretinism if untreated).
- Step Key molecule High-yield note
- Uptake NIS TSH-stimulated; "trapping"
- Organification/coupling TPO Target of PTU/methimazole; anti-TPO Abs in Hashimoto
- Storage Thyroglobulin colloid Large preformed store
- Activation Deiodinases T4 → T3; rT3 in illness
- Transport TBG Estrogen ↑ TBG (pregnancy, OCP) raises total T4 with normal free levels if euthyroid
Drug pearl: Thionamides inhibit TPO. PTU also inhibits peripheral T4→T3 (useful in thyroid storm conceptually) and is preferred in first-trimester pregnancy outlines; methimazole is often preferred otherwise. High-dose iodide can transiently inhibit organification ( Wolff–Chaikoff ); escape occurs in normal glands. Jod–Basedow is iodine-induced hyperthyroidism in autonomous nodules.
- Hyperthyroidism and Hypothyroidism Mechanisms
- Graves Disease
Autoimmune thyroid-stimulating immunoglobulins (TSIs) activate the TSH receptor → diffuse toxic goiter, high T3/T4, suppressed TSH. Unique findings: orbitopathy (TSH-receptor antigens in orbital fibroblasts), pretibial myxedema, thyroid bruit. Radioiodine uptake is diffusely increased.
Toxic Adenoma / Toxic Multinodular Goiter
Autonomous follicular nodules secrete thyroid hormone independent of TSH (somatic activating mutations in TSH-receptor/Gs pathways often invoked). Uptake is focal ("hot" nodule) or patchy; surrounding tissue is suppressed.
Hashimoto Thyroiditis
Most common cause of hypothyroidism in iodine-sufficient regions. Anti-TPO and anti-thyroglobulin antibodies; lymphocytic infiltration, Hurthle cells, germinal centers. Early destructive phase can release hormone ( hashitoxicosis ), then permanent hypothyroidism with high TSH and low free T4. Association with other autoimmune disease and slight increased thyroid lymphoma risk in longstanding goiters is classic trivia.
Other hypothyroidism causes
Iodine deficiency (worldwide), iatrogenic (surgery, radioiodine, drugs such as lithium, amiodarone), central hypothyroidism (low/normal TSH with low free T4).
Thyroid Storm and Myxedema Concepts
Thyroid storm: Extreme hyperthyroid physiology—fever, tachycardia/arrhythmia, altered mental status, often precipitated by infection, surgery, or iodine load. Pathophysiology is severe catecholamine sensitivity and metabolic acceleration; treatment concepts block synthesis (thionamides), block release (iodide after synthesis block), block T4→T3 (PTU, β-blockers, steroids), and supportive care.
Myxedema coma: Severe hypothyroidism—hypothermia, hypoventilation, hyponatremia, bradycardia, altered mentation. Non-pitting edema from glycosaminoglycan deposition. Treat with thyroid hormone and supportive care; rule out concurrent adrenal insufficiency before aggressive T3 in some protocols (exam-level awareness).
Thyroid Cancers (Associations Matter)
Type Origin / histology pearls Route / behavior Associations
Papillary Most common; Orphan Annie eye nuclei, nuclear grooves, psammoma bodies Lymphatic; excellent prognosis RET/PTC, BRAF; radiation exposure
Follicular Uniform follicles; capsular/vascular invasion defines carcinoma vs adenoma Hematogenous (bone, lung) RAS, PAX8-PPARγ
Medullary Parafollicular C cells ; amyloid stroma; calcitonin Lymphatic/hematogenous RET ; MEN2A/2B , familial MTC
Anaplastic Undifferentiated, elderly, rapidly enlarging Locally invasive, poor prognosis Often arises in longstanding goiter/prior DTC
Exam habit: Calcitonin or amyloid → medullary. Psammoma + orphan annie → papillary. Hematogenous spread emphasis → follicular. Older patient, rock-hard rapid mass → anaplastic. Always link medullary to MEN2 and pheochromocytoma screening conceptually.
Calcium Regulation: PTH, PTHrP, Vitamin D, Calcitonin
Parathyroid hormone (PTH) from chief cells responds within minutes to low ionized Ca2+ (calcium-sensing receptor, CaSR). PTH:
- Increases bone resorption (osteoclast activation via osteoblast RANKL axis)
- Increases renal Ca2+ reabsorption (distal nephron)
- Decreases renal phosphate reabsorption (proximal tubule → phosphaturia)
Stimulates renal 1α-hydroxylase → more 1,25-dihydroxyvitamin D , which increases intestinal Ca2+ and PO4 absorption
Net PTH effect: ↑ serum Ca2+, ↓ serum PO4 (and ↑ urinary cAMP/phosphate).
PTHrP activates the same PTH/PTHrP receptor—classic in humoral hypercalcemia of malignancy (squamous cell cancers, etc.): high Ca2+, low PTH, low/normal 1,25-D often, phosphaturia.
Vitamin D deficiency / CKD: impaired 1,25-D → low Ca2+ absorption → secondary hyperparathyroidism; CKD also retains phosphate, further driving PTH.
Calcitonin from C cells opposes high Ca2+ by inhibiting osteoclasts; relatively minor chronic regulator in adult humans but a tumor marker in medullary carcinoma.
State Ca2+ PO4 PTH Notes
Primary hyperparathyroidism ↑ ↓ ↑ or inappropriately normal Adenoma most common; "stones, bones, groans, psychiatric overtones"
- Malignancy (PTHrP) ↑ ↓ ↓ Suppressed PTH
- Secondary hyperparathyroidism (CKD) ↓ or normal ↑ ↑↑ Driven by hypocalcemia/hyperphosphatemia/low 1,25-D
- Tertiary hyperparathyroidism ↑ variable ↑↑ autonomous After prolonged secondary drive
- Hypoparathyroidism ↓ ↑ ↓ Post-surgical classic; Chvostek/Trousseau
- Vitamin D deficiency ↓/normal ↓ ↑ Secondary hyperparathyroidism
Primary hyperparathyroidism: usually parathyroid adenoma; hyperplasia in MEN1/MEN2A. High or nonsuppressed PTH with hypercalcemia is the biochemical key.
Secondary: physiologic PTH rise—CKD most tested; also vitamin D deficiency. Calcium is low or normal, not high (if calcium is high, think tertiary or primary).
Hypoparathyroidism: post-thyroidectomy accidental parathyroid removal/injury; autoimmune; DiGeorge (no parathyroids). Low PTH, low Ca2+, high PO4; neuromuscular irritability.
Pseudohypoparathyroidism (type 1a, Albright hereditary osteodystrophy): end-organ Gsα resistance to PTH → high PTH, low Ca2+, high PO4, plus short stature, short 4th/5th metacarpals when maternally inherited allele patterns apply (GNAS imprinting)—high-yield molecular pearl.
MEN Syndromes
Syndrome Major lesions Gene
MEN1 P arathyroid hyperplasia/adenomas, P ituitary adenoma, P ancreaticoduodenal NET (gastrinoma, insulinoma, etc.)—"3 Ps" MEN1 (menin)
MEN2A Medullary thyroid carcinoma, pheochromocytoma, hyperparathyroidism RET
MEN2B Medullary thyroid carcinoma, pheochromocytoma, mucosal neuromas, marfanoid habitus; not hyperparathyroidism RET
Prophylactic thyroidectomy concepts in MEN2 reflect nearly inevitable MTC risk—know the association more than surgical timing details.
Putting Thyroid and Parathyroid Together on Exams
A diffusely hot thyroid with orbitopathy is Graves, not a hot nodule. A cold nodule raises cancer concern (most cold nodules still benign, but cancers are cold). After neck surgery, acute tetany points to hypoparathyroidism, not hypothyroidism alone. Hypercalcemia with suppressed PTH is not primary hyperparathyroidism—look for PTHrP or osteolytic mets or vitamin D excess. Hypercalcemia with high PTH is primary (or tertiary). Medullary cancer plus pheo screams MEN2; parathyroid plus pituitary plus gastrinoma screams MEN1.
Wire synthesis steps to drug targets, antibodies to disease direction (stimulate vs destroy), calcium labs to the driving hormone, and tumors to their molecular/syndromic tags—and this section becomes a reliable point bank on the reproductive–endocrine slice of the CBSE.